Navigation Links
New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians
Date:10/11/2007

HAYWARD, Calif., Oct. 11 /PRNewswire/ -- Guava Technologies today launched a new corporate website with an infrastructure focused around its main audiences: Life Scientists, Flow Cytometrists, and Clinicians.

With flow cytometry being an essential tool for cell analysis, Guava Technologies is dedicated to finding innovative ways to make the technology as practical as possible for all life scientists and clinicians who work with cells. This dedication is obvious from the audience-centric organization of the new site, where the main choices on the home page for further investigation are targeted to the unique needs of the company's main markets: Life Science Research (i.e., pharma/biotech, academia/government, clinical research), Flow Cytometry, and Clinical Diagnostics.

While the website does offer traditional navigation, those links are secondary. The site is obviously built around the company's desire to serve its key market segments and stakeholders. According to Lawrence Bruder, CEO, the audience-centric organization was the obvious choice from the beginning: "Those individuals are the reason we are in business; the reason our employees come to work every day," said Mr. Bruder, "so given the importance of our website as a vehicle for two-way communication with them, it just made sense to focus it on their needs."

Guava Technologies encourages everyone interested in flow cytometry or the company to visit the site at http://www.guavatechnologies.com, and to let the company know what it can do to further improve the site based on their needs and interests.

Guava Technologies is a private biotechnology and medical device company. In 2001, it introduced the first commercial benchtop microcapillary flow cytometer with easy-to-use, assay-specific reagents and software. Since then, it has introduced numerous new systems and assays, always focusing on making flow cytometry more practical for life scientists and clinicians. Guava Systems do not require sheath fluid so accommodate smaller sample volumes, generate less waste, have lower daily operate costs, and are easier to set-up and maintain than traditional flow cytometers. And, all Guava Systems perform direct, absolute cell counts without reference beads. True to the company's goal, virtually any scientist or clinician can learn to operate a Guava System in less than one day.


'/>"/>
SOURCE Guava Technologies
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Selecting siRNA Sequences to Incorporate into the pSilencer Vectors
2. Pre-eminent, web-based companies owe success to corporate venturing
3. Corporate Social Responsibility - Burden, sham, or golden opportunity?
4. Corporate venturing can nurture software success
5. Enrons dilemma: A corporate governance nightmare
6. Getting beyond the vortex of corporate mediocrity
7. Corporate control begins with a strong board
8. Directors more assertive in corporate governance
9. The black hole of corporate branding
10. Corporate Americas hidden deficit
11. Business professor launches corporate reporting study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... , ... Bacterial biofilms, surface adherent communities of bacteria that are encased in ... poisoning and catheter infections to gum disease and the rejection of medical implants. ... per year, there is currently a paucity of means for preventing their formation or ...
(Date:5/22/2017)... Boston, MA (PRWEB) , ... May 22, 2017 , ... ... evidence, has expanded to the East Coast. It has opened an office in downtown ... innovative therapies are finding it increasingly more important to generate evidence on the value ...
(Date:5/21/2017)... , ... May 19, 2017 , ... ... and educational conference of the American Association of Bioanalysts (AAB) and the College ... in Houston. The conference reinforces AAB’s commitment to excellence in clinical laboratory services ...
(Date:5/19/2017)... PA (PRWEB) , ... May 19, 2017 , ... ... its QED Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, and ... New Jersey and Delaware, are encouraged to submit proposals. QED, now in its ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
Breaking Biology News(10 mins):